Evidence map›Paper›PMID 40405334›Full record

ArticleAnnals of geriatric medicine and research2025

Community-Acquired Pneumonia with Pseudomonas aeruginosa in a Geriatric Patient with Rheumatoid Arthritis under Baricitinib Treatment.

Eva Grundmann, Ghazala Gohar, Simon Meier, Bertram Feil, Michael Gagesch

Abstract readCase Reports
In one paragraph

Article in Annals of geriatric medicine and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eva GrundmannUniversitäre Klinik für Altersmedizin, Stadtspital Zürich, Zurich, Switzerland.
Ghazala GoharUniversitäre Klinik für Altersmedizin, Stadtspital Zürich, Zurich, Switzerland.
Simon MeierUniversitäre Klinik für Altersmedizin, Stadtspital Zürich, Zurich, Switzerland.
Bertram FeilInstitut für Radiologie und Nuklearmedizin, Stadtspital Zürich, Zurich, Switzerland.
Michael GageschUniversitäre Klinik für Altersmedizin, Stadtspital Zürich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Community-acquired pneumonia (CAP) in older patients presents unique diagnostic challenges. Unlike typical presentations with fever and cough, older adults may experience atypical symptoms like falls, confusion, or chronic disease deterioration. Immunomodulatory treatments for autoimmune diseases further complicate infection risks. This is the first case of a severe Pseudomonas aeruginosa pneumonia in an 86-year-old rheumatoid arthritis patient on baricitinib and prednisone. Initially admitted after a fall, she showed no respiratory symptoms but had a chest x-ray revealing extensive infiltrative consolidation. Sputum analysis confirmed the pneumonia, which was successfully treated with antibiotics. Following the resolution of the infection, the immunomodulatory therapy could be safely reintroduced. The case underscores the critical need for comprehensive diagnostic evaluation in older adults on immunomodulatory therapy, emphasizing that subtle, non-respiratory symptoms can mask serious infections and require heightened clinical suspicion.

Indexed as

Antirheumatic AgentsArthritis, RheumatoidAzetidinesCommunity-Acquired InfectionsPneumonia, BacterialPseudomonas aeruginosaPseudomonas InfectionsPyrazolesSulfonamidesAged, 80 and overAnti-Bacterial AgentsCommunity-Acquired PneumoniaFemaleHumansPurinesAnti-Bacterial AgentsAntirheumatic AgentsAzetidinesbaricitinibPurinesPyrazolesSulfonamidesBaricitinibPseudomonas aeruginosaRheumatoid arthritis

Identifiers

PMID40405334
PMCPMC12489608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.